101 related articles for article (PubMed ID: 30673611)
1. Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes.
Zhao Y; Feng Z; Zhang Y; Sun Y; Chen Y; Liu X; Li S; Zhou T; Chen L; Wei Y; Ma D; Lui KO; Ying H; Chen Y; Ding Q
Cell Rep; 2019 Jan; 26(4):884-892.e4. PubMed ID: 30673611
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Variants in the SLC16A11 Coding Region Are Not Loss-of-Function Mutations.
Zhao Y; Feng Z; Ding Q
Cell Rep; 2019 Oct; 29(3):781-784. PubMed ID: 31618644
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data.
Hoch E; Florez JC; Lander ES; Jacobs SBR
Cell Rep; 2019 Oct; 29(3):778-780. PubMed ID: 31618643
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.
Rusu V; Hoch E; Mercader JM; Tenen DE; Gymrek M; Hartigan CR; DeRan M; von Grotthuss M; Fontanillas P; Spooner A; Guzman G; Deik AA; Pierce KA; Dennis C; Clish CB; Carr SA; Wagner BK; Schenone M; Ng MCY; Chen BH; ; ; Centeno-Cruz F; Zerrweck C; Orozco L; Altshuler DM; Schreiber SL; Florez JC; Jacobs SBR; Lander ES
Cell; 2017 Jun; 170(1):199-212.e20. PubMed ID: 28666119
[TBL] [Abstract][Full Text] [Related]
5. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.
; Williams AL; Jacobs SB; Moreno-Macías H; Huerta-Chagoya A; Churchhouse C; Márquez-Luna C; García-Ortíz H; Gómez-Vázquez MJ; Burtt NP; Aguilar-Salinas CA; González-Villalpando C; Florez JC; Orozco L; Haiman CA; Tusié-Luna T; Altshuler D
Nature; 2014 Feb; 506(7486):97-101. PubMed ID: 24390345
[TBL] [Abstract][Full Text] [Related]
6. The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes.
Kimura Y; Higuchi I; Kobayashi M; Furugen A; Narumi K; Suzuki Y; Miyoshi H; Nakamura A; Atsumi T; Iseki K
Drug Metab Pharmacokinet; 2021 Apr; 37():100376. PubMed ID: 33561739
[TBL] [Abstract][Full Text] [Related]
7. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
Almeda-Valdes P; Gómez Velasco DV; Arellano Campos O; Bello-Chavolla OY; Del Rocío Sevilla-González M; Viveros Ruiz T; Martagón Rosado AJ; Bautista CJ; Muñoz Hernandez L; Cruz-Bautista I; Moreno-Macias H; Huerta-Chagoya A; Rodríguez-Álvarez KG; Walford GA; Jacobs SBR; Guillen Pineda LE; Ordoñez-Sánchez ML; Roldan-Valadez E; Azpiroz J; Furuzawa-Carballeda J; Clark P; Herrera-Hernández MF; Zambrano E; Florez JC; Tusié Luna MT; Aguilar-Salinas CA
Eur J Endocrinol; 2019 Feb; 180(2):99-107. PubMed ID: 30475225
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in the
Mardones L; Petermann-Rocha F; Martinez-Sanguinetti MA; Leiva AM; Troncoso-Pantoja C; Martorell M; Lasserre N; Ulloa N; Perez-Bravo F; Celis-Morales C; Villagran M;
Arch Endocrinol Metab; 2021 Nov; 65(3):305-314. PubMed ID: 33909378
[TBL] [Abstract][Full Text] [Related]
9. Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Hidalgo BA; Sofer T; Qi Q; Schneiderman N; Chen YI; Kaplan RC; Avilés-Santa ML; North KE; Arnett DK; Szpiro A; Cai J; Yu B; Boerwinkle E; Papanicolaou G; Laurie CC; Rotter JI; Stilp AM
Sci Rep; 2019 Jan; 9(1):843. PubMed ID: 30696834
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of SLC16A11 is Present in Offspring of Mothers with Gestational Diabetes.
Sevilla-Domingo M; Olivo-Ramirez CG; Huerta-Padilla VM; Gómez-Díaz RA; González-Carranza E; Acevedo-Rodriguez GE; Hernandez-Zuñiga VE; Gonzalez ALV; Mateos-Sanchez L; Mondragon-Gonzalez R; Garrido-Magaña EP; Ramirez-Garcia LA; Wacher NH; Vargas MS
Arch Med Res; 2022 Jul; 53(5):516-523. PubMed ID: 35831226
[TBL] [Abstract][Full Text] [Related]
11. The role of SLC16A11 variations in diabetes mellitus.
Aguilar-Salinas CA; Tusie Luna MT
Curr Opin Nephrol Hypertens; 2023 Sep; 32(5):445-450. PubMed ID: 37530085
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes.
Huang S; Huang S; Wang X; Zhang Q; Liu J; Leng Y
Int J Biol Sci; 2017; 13(1):1-12. PubMed ID: 28123341
[TBL] [Abstract][Full Text] [Related]
13. Associations of common variants in the SLC16A11, TCF7L2, and ABCA1 genes with pediatric-onset type 2 diabetes and related glycemic traits in families: A case-control and case-parent trio study.
Miranda-Lora AL; Cruz M; Molina-Díaz M; Gutiérrez J; Flores-Huerta S; Klünder-Klünder M
Pediatr Diabetes; 2017 Dec; 18(8):824-831. PubMed ID: 28101933
[TBL] [Abstract][Full Text] [Related]
14. Analysis of SLC16A11 Variants in 12,811 American Indians: Genotype-Obesity Interaction for Type 2 Diabetes and an Association With RNASEK Expression.
Traurig M; Hanson RL; Marinelarena A; Kobes S; Piaggi P; Cole S; Curran JE; Blangero J; Göring H; Kumar S; Nelson RG; Howard BV; Knowler WC; Baier LJ; Bogardus C
Diabetes; 2016 Feb; 65(2):510-9. PubMed ID: 26487785
[TBL] [Abstract][Full Text] [Related]
15. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
16. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats.
Mao ZJ; Weng SY; Lin M; Chai KF
J Ethnopharmacol; 2019 Oct; 243():111966. PubMed ID: 31128151
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus.
Wu CZ; Ou SH; Chang LC; Lin YF; Pei D; Chen JS
Molecules; 2019 Nov; 24(23):. PubMed ID: 31756973
[TBL] [Abstract][Full Text] [Related]
18. Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes.
Lara-Riegos JC; Ortiz-López MG; Peña-Espinoza BI; Montúfar-Robles I; Peña-Rico MA; Sánchez-Pozos K; Granados-Silvestre MA; Menjivar M
Gene; 2015 Jul; 565(1):68-75. PubMed ID: 25839936
[TBL] [Abstract][Full Text] [Related]
19. Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus.
Burgdorf C; Hänsel L; Heidbreder M; Jöhren O; Schütte F; Schunkert H; Kurz T
Biochem Biophys Res Commun; 2009 Dec; 390(1):165-70. PubMed ID: 19799857
[TBL] [Abstract][Full Text] [Related]
20. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
